Sinovac Biotech, Other Current Liabilities

Sinovac Biotech, (SVA) currently reports a other current liabilities of $120M as of June 2024. That compares with $140M in the prior-year period — down 14.5% year over year. Use the charts on this page to explore Sinovac Biotech,'s other current liabilities history and peer comparisons.

Sinovac Biotech,'s other current liabilities decreased from $140M to $120M — a 14.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sinovac Biotech, reported $120M in other current liabilities as of June 2024. That compares with $140M in the prior-year period — down 14.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sinovac Biotech,, and consider following SVA for alerts when major investors trade the stock.

Sinovac Biotech, is classified in the Healthcare sector. On other current liabilities, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SVA with unrelated industries.